Literature DB >> 22192754

Permanent epicardial pacing in pediatric patients: 12-year experience at a single center.

Jae Gun Kwak1, Soo-Jin Kim, Jin Young Song, Eun Young Choi, Sang Yoon Lee, Woo Sup Shim, Chang-Ha Lee, Cheul Lee, Chun Soo Park.   

Abstract

BACKGROUND: Permanent cardiac pacing is not often done in children, and when done is usually accomplished through epicardial pacing. We reviewed a 12-year experience with the implantation of epicardial pacemakers by our clinical group.
METHODS: Fifty-three patients who underwent their first implantation of an epicardial pacemaker before the age of 18 years and between 1997 and 2009 were included in our study. The mean age of the patients at the time of first pacemaker implantation was 5.7±4.8 years. Indications for pacemaker implantation included postoperative or congenital atrioventricular block and sinus node dysfunction. The patients underwent 105 operations for the replacement of pacemaker pulse generators and 75 operations for the replacement of pacemaker leads. The most commonly used generator mode was the rate-responsive accelerometer-based (DDDR) mode, which was used in 40.9% of the patients. We used more non-steroid-eluting leads (70.1%) than steroid-eluting leads (29.1%).
RESULTS: The overall duration of follow-up in the study was 8.0±4.5 years (range, 2.1 months to approximately 17.0 years). Freedom from the need for generator replacement was 98.0%, 60.7%, and 11.1% at 1, 5, and 8 years, respectively. A tendency toward early generator exhaustion was observed among younger patients (p=0.058). The generator mode used for pacing did not significantly affect generator longevity. Freedom from the need for lead replacement was 98.3%, 83.8%, and 63.6% at 1, 5, and 10 years, respectively. The mean longevity of the leads used in the study was 10.8±0.8 years. Neither patient age at the time of lead implantation nor type of lead significantly affected lead longevity.
CONCLUSIONS: Lead longevity was sufficiently long and did not vary significantly according to type of lead. Generator longevity was not affected by lead type, generator mode, or patient age at the time of pacemaker implantation.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22192754     DOI: 10.1016/j.athoracsur.2011.09.072

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Permanent epicardial pacing in neonates and infants less than 1 year old: 12-year experience at a single center.

Authors:  Junfei Zhao; Ying Huang; Liming Lei; Zeyang Yao; Tian Liu; Hailong Qiu; Canhui Lin; Xiaobing Liu; Yun Teng; Xiaohua Li; Yong Zhang; Jian Zhuang; Jimei Chen; Shusheng Wen
Journal:  Transl Pediatr       Date:  2022-06

2.  Device therapy in children with and without congenital heart disease.

Authors:  Jan Janoušek
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-07-29

3.  Treatment of Congenital Complete Atrioventricular Heart Block With Permanent Epicardial Pacemaker in Neonatal Lupus Syndrome.

Authors:  Sema Tanriverdi; Zulal Ulger; Betul Siyah Bilgin; Nilgun Kultursay; Mehmet Yalaz; Yuksel Atay; Ozge Altun Koroglu
Journal:  Iran Red Crescent Med J       Date:  2015-09-01       Impact factor: 0.611

4.  Performance of steroid eluting bipolar epicardial leads in pediatric and congenital heart disease patients: 15 years of single center experience.

Authors:  Christian Paech; Martin Kostelka; Ingo Dähnert; Patrick Flosdorff; Frank Thomas Riede; Roman Antonin Gebauer
Journal:  J Cardiothorac Surg       Date:  2014-05-12       Impact factor: 1.637

5.  Single chamber permanent epicardial pacing for children with congenital heart disease after surgical repair.

Authors:  Tao Zhang; Yiwei Liu; Chengwei Zou; Hao Zhang
Journal:  J Cardiothorac Surg       Date:  2016-04-12       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.